Mahkam Zanganeh, Chief Executive Officer at Summit Therapeutics Inc. (SMMT), bought 144,642 shares at $3.71 ($539K) on 2024-03-27, disclosed to the SEC on 2024-03-27.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.75 | 30,000 | $113K | 20.9% |
| 2 | $3.71 | 20,000 | $74K | 13.8% |
| 3 | $3.72 | 26,000 | $97K | 18.0% |
| 4 | $3.72 | 34,321 | $128K | 23.7% |
| 5 | $3.72 | 34,321 | $128K | 23.7% |
| Total | $3.72 avg | 144,642 |
| $539K |
| 100% |
| Filing → |
| SMMT | BUY | 2025-10-23 | $1000K | — | Filing → |
| SMMT | BUY | 2025-09-11 | $11.9M | — | Filing → |
| SMMT | BUY | 2023-12-13 | $10K | — | Filing → |